Concomitant Vancomycin-Resistant <it><bold>Enterococcus faecium</it></bold> and <it><bold>Clostridium difficile</it></bold> Colitis

被引:1
|
作者
Mehershahi, Shehriyar [1 ]
Ghazanfar, Haider [2 ]
Ashraf, Shoaib [2 ]
Shaikh, DanialH. [1 ]
Ihimoyan, Ariyo [1 ]
机构
[1] Bronxcare Hlth Syst, Dept Gastroenterol, Bronx, NY USA
[2] Bronxcare Hlth Syst, Dept Med, 1650 Selwyn Ave 10 C, Bronx, NY 10457 USA
关键词
Colitis; Vancomycin-resistant Enterococcus faecium; Clostridium difficile; Intensive care unit; COLONIZATION;
D O I
10.1159/000513165
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Colitis is a chronic gastrointestinal system disease characterized by inflammation of the inner lining of the colon. Infectious colitis is one of the most common causes of colitis and is associated with significant mortality and morbidity. One of the rare causes of colitis includes vancomycin-resistant Enterococcus faecium (VRE). Lately, the prevalence of VRE has significantly increased in hospitals. We present a case of a 32-year-old American man who was initially admitted because of bilateral lower extremity weakness. The hospital course was complicated, with acute hypoxic respiratory failure secondary to pneumonia. The patient was intubated and was started on broad-spectrum antibiotics. Later on, the patient had severe diarrhea and was found to have clostridium difficile infection. Patient symptoms persisted despite completing the course of antibiotics. Colonoscopy was performed, and the patient was found to have a diffuse area of severely altered vascular, congested, erythematous, friable with contact bleeding, hemorrhagic, inflamed, nodular, and ulcerated mucosa in the sigmoid colon, in the descending colon, and the transverse colon. A biopsy was sent, and the patient was found to be growing VRE. Currently, there is no effective treatment available for VRE. Hospitals need to have an active surveillance program to identify these patients so that the infection does not spread to other patients. (C) 2021 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:372 / 378
页数:7
相关论文
共 50 条
  • [11] Vancomycin-resistant Enterococcus faecium
    Marovac, J
    Campos, MI
    REVISTA MEDICA DE CHILE, 2000, 128 (06) : 685 - 686
  • [13] Clostridium difficile and vancomycin-resistant enterococcus:: The new nosocomial alliance
    Poduval, RD
    Kamath, RP
    Corpuz, M
    Norkus, EP
    Pitchumoni, CS
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (12): : 3513 - 3515
  • [14] <bold>A</bold> Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure
    Tartof, Sara Y.
    Rieg, Gunter K.
    Wei, Rong
    Tseng, Hung Fu
    Jacobsen, Steven J.
    Yu, Kalvin C.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2015, 36 (12): : 1409 - 1416
  • [15] Vancomycin-resistant Enterococcus faecium Meningitis
    Dayan, S.
    Senses, E.
    Bekcibasi, M.
    Yilmaz, T.
    Deveci, O.
    Tekin, R.
    WEST INDIAN MEDICAL JOURNAL, 2016, 65 (03): : 585 - 585
  • [16] Vancomycin-resistant Enterococcus faecium meningitis
    Lopez Castro, Jose
    Pintado Garcia, Vicente
    Medina-Gens, Leila
    Rojo Rodriguez, Carmen
    MEDICINA CLINICA, 2007, 129 (03): : 116 - 117
  • [17] Vancomycin-resistant Enterococcus faecium colonisations
    Ferguson, J
    Butt, H
    Johnson, C
    Boyle, M
    MEDICAL JOURNAL OF AUSTRALIA, 1996, 165 (05) : 292 - 293
  • [18] Genomics of vancomycin-resistant Enterococcus faecium
    Gorrie, Claire
    Higgs, Charlie
    Carter, Glen
    Stinear, Timothy P.
    Howden, Benjamin
    MICROBIAL GENOMICS, 2019, 5 (07):
  • [19] Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile
    Salgado, CD
    Giannetta, ET
    Farr, BM
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (05): : 413 - 417
  • [20] Beneficial effects of oxymatrine from Sophora flavescens on alleviating <bold>Ulcerative colitis</bold> by improving inflammation and ferroptosis
    Gao, Bing Bing
    Wang, Li
    Li, Lin Zi
    Fei, Zhang Qing
    Wang, Yu Yan
    Zou, Xiao Ming
    Huang, Min Cong
    Lei, Shan Shan
    Li, Bo
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 332